HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Human T-cell leukaemia/lymphoma virus risk may be enhanced in some selected donor populations.

AbstractBACKGROUND AND OBJECTIVES:
Certain patient ethnic groups may require blood components from donors under-represented in the UK donor population. Selective recruitment of Afro-Caribbean donors is therefore necessary but was considered to pose an increased risk of human T-cell leukaemia/lymphoma virus (HTLV) infection. To assess this a seroprevalence study of HTLV was undertaken in Afro-Caribbean and Caucasian donors.
MATERIALS AND METHODS:
Sera from 1100 Afro-Caribbean and 1100 Caucasian donors were tested for antibody to HTLV. Reactive samples were confirmed for specificity using an algorithm comprising two additional assays and polymerase chain reaction (PCR) where possible.
RESULTS:
Six Afro-Caribbean donors (0.55%) were considered to be infected with HTLV I.
CONCLUSION:
Donor selection in this case caused a significantly elevated prevalence of HTLV infection and serves as a warning of the need for care in the design of policies for selective donor recruitment.
AuthorsJ Price, B A Cant, J A Barbara, R S Tedder
JournalVox sanguinis (Vox Sang) Vol. 80 Issue 3 Pg. 148-50 (Apr 2001) ISSN: 0042-9007 [Print] England
PMID11449953 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • HTLV-I Antibodies
  • RNA, Viral
  • Reagent Kits, Diagnostic
Topics
  • Adult
  • Africa (ethnology)
  • Blood Donors
  • Ethnicity
  • HTLV-I Antibodies (blood)
  • HTLV-I Infections (blood, ethnology, prevention & control, transmission)
  • Human T-lymphotropic virus 1 (isolation & purification)
  • Humans
  • Mass Screening
  • Polymerase Chain Reaction
  • Prevalence
  • RNA, Viral (blood)
  • Reagent Kits, Diagnostic
  • Risk
  • Seroepidemiologic Studies
  • Transfusion Reaction
  • United Kingdom (epidemiology)
  • Viremia (ethnology, prevention & control, transmission)
  • West Indies (ethnology)
  • White People

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: